Childhood Acute Megakaryocytic Leukemia (M7) Completed Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00666588Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid LeukemiaTreatment